vaccine trial by Pfizer
COVID-19 vaccine trial by Pfizer shows mild-to-moderate side effects
Participants of a phase 3 clinical trial of American biopharmaceutical company Pfizer's COVID-19 vaccine candidate were experiencing mild-to-moderate side effects, said the company on Tuesday.